Related references
Note: Only part of the references are listed.A review of pediatric neuroendocrine tumors, their detection, and treatment by radioisotopes
Tara Haddad et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
Diagnosis, Treatment Response, and Prognosis: The Role of 18F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with 123I-mIBG Scan: The First Prospective Study
Arnoldo Piccardo et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Samuel W. Brady et al.
NATURE COMMUNICATIONS (2020)
Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)
Navin Pinto et al.
EUROPEAN JOURNAL OF CANCER (2019)
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma A Randomized Clinical Trial
Julie R. Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children’s Oncology Group Study ANBL0531
Clare J. Twist et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study
Hiram Shaish et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Guidelines on nuclear medicine imaging in neuroblastoma
Zvi Bar-Sever et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer
Sung Uk Bae et al.
CANCER IMAGING (2018)
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma
Natasha Alexander et al.
CURRENT RADIOPHARMACEUTICALS (2018)
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
Julie R. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Persistent positive metaiodobenzylguanidine scans after autologous peripheral blood stem cell transplantation may indicate maturation of stage 4 neuroblastoma
Yasuhiro Okamoto et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2017)
Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT
Chia-Ju Liu et al.
CLINICAL NUCLEAR MEDICINE (2017)
Telomere maintenance is pivotal for high-risk neuroblastoma
Falk Hertwig et al.
CELL CYCLE (2016)
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131I-metaiodobenzylguanidine
Kelly E. Huibregtse et al.
EUROPEAN JOURNAL OF CANCER (2016)
Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis
Tomoko Iehara et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma
Cormac Owens et al.
PEDIATRIC BLOOD & CANCER (2016)
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R. Pinto et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Neuroblastoma Paradigm for Precision Medicine
Meredith S. Irwin et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Striking Dichotomy in Outcome of MYCN-Amplified Neuroblastoma in the Contemporary Era
Brian H. Kushner et al.
CANCER (2014)
Treatment of Two Cases With Refractory, Metastatic Intermediate-Risk Neuroblastoma With Isotretenoin Alone or Observation
Navin Pinto et al.
PEDIATRIC BLOOD & CANCER (2014)
SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions
Thomas C. Kwee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group
Gregory A. Yanik et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Current and Future Strategies for Relapsed Neuroblastoma: Challenges on the Road to Precision Therapy
Daniel A. Morgenstern et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G. Kreissman et al.
LANCET ONCOLOGY (2013)
Long-term follow-up of children with high-risk neuroblastoma: The ENSG5 trial experience
Lucas Moreno et al.
PEDIATRIC BLOOD & CANCER (2013)
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
Julie R. Park et al.
PEDIATRIC BLOOD & CANCER (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma
Araz Marachelian et al.
PEDIATRIC BLOOD & CANCER (2012)
Survival and Late Effects in Children With Stage 4 Neuroblastoma
Thomas Perwein et al.
PEDIATRIC BLOOD & CANCER (2011)
Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
Herve J. Brisse et al.
RADIOLOGY (2011)
Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
K. K. Matthay et al.
BRITISH JOURNAL OF CANCER (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
P. F. Ambros et al.
BRITISH JOURNAL OF CANCER (2009)
Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
Brian H. Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
Susan E. Sharp et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study
Caroline Laverdiere et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastorna >1 year of age on a high-risk treatment protocol:: Results of the German Neuroblastoma Trial NB97
Matthias Schmidt et al.
EUROPEAN JOURNAL OF CANCER (2008)
Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation
T. N. Trahair et al.
BONE MARROW TRANSPLANTATION (2007)
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules
Ayesha S. Bryant et al.
ANNALS OF THORACIC SURGERY (2006)
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma:: A Pediatric Oncology Group Study
RE George et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Extending positron emission tomography scan utility to high-risk neuroblastoma: Fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
